Theralase Technologies Inc. V.TLT

Alternate Symbol(s): V.TLT.WT | TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by langostaon Dec 12, 2017 5:23pm

110 Views

Post# 27142087

RE:RE:RE:RE:So TLT announces breakthrough cancer tech on regular basis

Mineking66 wrote: First off the secrecy needs to end... Was the trial suspended after patient number 4 having adverse reactions? What about the remaining individuals that were to be part of the trial?

Question: Would the above not fall under the "Newsworthy Item" category. and an NR put out under Notable Failure, or some such other headline?

Bullboard Posts

Revolutionizing medical imaging with nanocarbon-based contrast drugs